In collaboration with the European Commission and the European Green Vehicles Initiative Association, European countries and regions will set-up an ERA-NET Cofund to further promote electric mobility in Europe. Electric Mobility Europe builds on the experiences, networks and results of Electromobility+ and is designed to take transnational e-mobility research and policy exchange to the next level. With a two-track approach, the initiative will link research and policy practice in support of electric mobility at the European level. The first of two pillars of Electric Mobility Europe will fund innovation projects focussing on the application and demonstration of e-mobility with the objective of advancing the mainstreaming of the electrification of mobility in Europe. The initiative will bring together about 30 million EUR for supporting applied innovation projects, including up to 10 million EUR of co-funding provided by the European Commission under Horizon 2020. In 2016, the initiative will issue a call for project proposals addressing the key areas of electric mobility: 1. System integration (transport, (sub)urban areas) 2. Integration of urban freight and city logistics in the e-mobility 3. Smart Mobility concepts and ICT applications 4. Public transport 5. Consumer behaviour and societal trends In addition to funding innovation and demonstration projects, the ERA-NET Cofund Electric Mobility Europe will establish a second pillar of activity. The network will provide a platform for cooperation and exchange of information and experiences among participating countries and regions. In this context, know-how will be shared on setting conducive conditions for the development of electric mobility in Europe (e.g. on charging infrastructure). The network will support this by facilitating suitable means of cooperation such as workshops or seminars in order to exchange or coordinate required actions, in attunement with the European Green Vehicle Initiative Association.

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure the wellbeing of an increasingly aged population. EuroNanoMed III (ENM III) builds on the foundations of ENM I & II, which launched 7 successful joint calls for proposals since 2009, funded 51 transnational research projects involving 269 partners from 25 countries/regions, and allocated € 45,5 million to research projects from ENM funding agencies. ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to fostering the competiveness of European nanomedicine actors taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the SRIA in nanomedicine. The first joint call for proposals will be co-funded by ENM III partners and the EC. After the co-funded call, three additional joint transnational calls will be organized and strategic activities will be accomplished in collaboration with key initiatives in the field. ENM III actions focus on translatability of project results to clinical and industry needs.